Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 36, 2023 - Issue 5
Submit an article Journal homepage
46
Views
0
CrossRef citations to date
0
Altmetric
Original Research - Gastroenterology

Association of nonalcoholic fatty liver disease with acute cholangitis: a nationwide propensity-matched analysis from the United States

Pratik Patela Mather Hospital and Hofstra University Zucker School of Medicine, Port Jefferson, New York, USA
, MD,
Faisal Inayatb Allama Iqbal Medical College, Lahore, Punjab, PakistanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7576-7319
, MBBSORCID Icon,
Hassam Alic East Carolina University Brody School of Medicine, Greenville, North Carolina, USA
, MD,
Arslan Afzald Woodhull Medical Center, Brooklyn, New York, USA
, MD,
Sobaan Taje Jersey Shore University Medical Center, Neptune, New Jersey, USA
, MD,
Attiq Ur Rehmanf Mercy Medical Center, Baltimore, Maryland, USA
, MD,
Nadeem Hussainb Allama Iqbal Medical College, Lahore, Punjab, Pakistan
, MD,
Rizwan Ishtiaqg Saint Francis Hospital and Medical Center, Hartford, Connecticut, USA
, MD,
Gul Nawazb Allama Iqbal Medical College, Lahore, Punjab, Pakistan
, MD,
Muhammad Sohaib Afzalh Louisiana State University Health, Shreveport, Louisiana, USA
, MD,
Karina Fatakhovaa Mather Hospital and Hofstra University Zucker School of Medicine, Port Jefferson, New York, USA
, MD &
Sanjaya K. Satapathyi North Shore University Hospital and Hofstra University Zucker School of Medicine, Manhasset, New York, USA
, MD show all
Pages 600-607 | Received 26 Apr 2023, Accepted 24 Jun 2023, Published online: 17 Jul 2023

  • Centers for Disease Control and Prevention. Adult obesity facts. 2022. https://www.cdc.gov/obesity/data/adult.html. Accessed January 20, 2023.
  • Sarwar R, Pierce N, Koppe S. Obesity and nonalcoholic fatty liver disease: current perspectives. Diabetes Metab Syndr Obes. 2018;11:533–542. doi:10.2147/DMSO.S146339.
  • Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities. Front Med (Lausanne). 2020;7:448. doi:10.3389/fmed.2020.00448.
  • Wai-Sun Wong V, Ekstedt M, Lai-Hung Wong G, Hagström H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023 May 9. Online ahead of print. doi:10.1016/j.jhep.2023.04.036.
  • Lyu J, Lin Q, Fang Z, Xu Z, Liu Z. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease. Front Endocrinol (Lausanne). 2022;13:1032557. doi:10.3389/fendo.2022.1032557.
  • Arrese M, Cortés V, Barrera F, Nervi F. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship. Curr Opin Gastroenterol. 2018;34(2):90–96. doi:10.1097/MOG.0000000000000416.
  • Lu Y, Hu L, Song J, Wan J, Chen H, Yin J. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study. BMC Endocr Disord. 2021;21(1):231. doi:10.1186/s12902-021-00899-z.
  • Maeda S, Hikiba Y, Fujiwara H, et al. NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice. Cancer Sci. 2021;112(4):1471–1480. doi:10.1111/cas.14828.
  • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9. doi:10.1016/j.ijsu.2014.07.013.
  • Khera R, Angraal S, Couch T, et al. Adherence to methodological standards in research using the National Inpatient Sample. JAMA. 2017;318(20):2011–2018. doi:10.1001/jama.2017.17653.
  • Menendez ME, Neuhaus V, van Dijk CN, Ring D. The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery. Clin Orthop Relat Res. 2014;472(9):2878–2886. doi:10.1007/s11999-014-3686-7.
  • Fatakhova K, Patel P, Inayat F, et al. Trends in hospital admissions and mortality among inflammatory bowel disease patients with substance use disorder: a 10-year United States nationwide analysis. Proc (Bayl Univ Med Cent). 2023;36(4):427–433. doi:10.1080/08998280.2023.2204535.
  • Patel P, Ali H, Inayat F, et al. Racial and gender-based disparities and trends in common psychiatric conditions in liver cirrhosis hospitalizations: A ten-year United States study. World J Hepatol. 2023;15(2):289–302. doi:10.4254/wjh.v15.i2.289.
  • Ahmed M. Acute cholangitis—an update. World J Gastrointest Pathophysiol. 2018;9(1):1–7. doi:10.4291/wjgp.v9.i1.1.
  • Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol. 2012;47(2):197–203. doi:10.3109/00365521.2011.643481.
  • Kichloo A, Solanki S, Haq KF, et al. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. World J Gastrointest Pathophysiol. 2021;12(2):14–24. doi:10.4291/wjgp.v12.i2.14.
  • Erlinger S. Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol. 2000;12(12):1347–1352. doi:10.1097/00042737-200012120-00015.
  • Bonfrate L, Wang DQ, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol. 2014;28(4):623–635. doi:10.1016/j.bpg.2014.07.013.
  • Sbeit W, Sbeit M, Kalisky I, Katz L, Mari A, Khoury T. The possible association of non-alcoholic fatty liver disease with acute cholangitis: a retrospective multicenter cohort study. Life (Basel). 2021;12(1):35. doi:10.3390/life12010035.
  • Nakagawa H, Hikiba Y, Hirata Y, et al. Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis. Proc Natl Acad Sci U S A. 2014;111(3):1090–1095. doi:10.1073/pnas.1322731111.
  • Maeda S, Nakagawa H. Roles of E-cadherin in hepatocarcinogenesis. In: Nakao K, Minato N, Uemoto S, eds. Innovative Medicine: Basic Research and Development. Tokyo: Springer; 2015. doi:10.1007/978-4-431-55651-0_6.
  • Bang KB, Cho YK. Comorbidities and metabolic derangement of NAFLD. J Lifestyle Med. 2015;5(1):7–13. doi:10.15280/jlm.2015.5.1.7.
  • Glass LM, Hunt CM, Fuchs M, Su GL. Comorbidities and nonalcoholic fatty liver disease: the chicken, the egg, or both? Fed Pract. 2019;36(2):64–71.
  • Lee TW, Bae E, Chang SH, et al. Impact of chronic kidney disease on the outcome of acute cholangitis. Nephrology. 2019;24:35–43. doi:10.1111/nep.13651.
  • Loosen SH, Essing T, Jördens M, et al. Current epidemiological trends and in-hospital mortality of acute pancreatitis in Germany: a systematic analysis of standardized hospital discharge data between 2008 and 2017. Z Gastroenterol. 2022;60(3):310–319. doi:10.1055/a-1682-7621.
  • Abdel-Razik A, Mousa N, Shabana W, et al. De novo portal vein thrombosis in non-cirrhotic non-alcoholic fatty liver disease: a 9-year prospective cohort study. Front Med (Lausanne). 2021;8:650818. doi:10.3389/fmed.2021.650818.
  • Byrne CD, Targher G. NAFLD as a driver of chronic kidney disease. J Hepatol. 2020;72(4):785–801. doi:10.1016/j.jhep.2020.01.013.
  • Musso G, Gambino R, Tabibian JH, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7):e1001680. doi:10.1371/journal.pmed.1001680.
  • Machado MV, Gonçalves S, Carepa F, Coutinho J, Costa A, Cortez-Pinto H. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. Liver Int. 2012;32(2):241–248. doi:10.1111/j.1478-3231.2011.02623.x.
  • Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51(3):444–450. doi:10.1007/s00125-007-0897-4.
  • Sommerfeld O, von Loeffelholz C, Diab M, et al. Association between high dose catecholamine support and liver dysfunction following cardiac surgery. J Card Surg. 2020;35(6):1228–1236. doi:10.1111/jocs.14555.
  • Sterling RK, Shin D, Shin Y, et al. Fibrosis-4 predicts the need for mechanical ventilation in a national multiethnic cohort of corona virus disease 2019. Hepatol Commun. 2021;5(9):1605–1615. doi:10.1002/hep4.1737.
  • Chang Y, Jeon J, Song TJ, Kim J. Association between the fatty liver index and the risk of severe complications in COVID-19 patients: a nationwide retrospective cohort study. BMC Infect Dis. 2022;22(1):384. doi:10.1186/s12879-022-07370-x.
  • Alexander M, Loomis AK, Fairburn-Beech J, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16(1):130. doi:10.1186/s12916-018-1103-x.
  • Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.e1. doi:10.1053/j.gastro.2019.11.312.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.